Nov. 6, 2025 — Lattice Semiconductor (LSCC) Matches Q3, Guides 22% Q4 Growth; Benchmark Electronics (BHE) Files 10‑Q After Mixed Quarter

Nov. 6, 2025 — Lattice Semiconductor (LSCC) Matches Q3, Guides 22% Q4 Growth; Benchmark Electronics (BHE) Files 10‑Q After Mixed Quarter

Updated Nov. 6, 2025 — Shares of Lattice Semiconductor (NASDAQ: LSCC) and Benchmark Electronics (NYSE: BHE) remain in focus today as investors digest fresh filings, analyst reactions, and guidance following this week’s earnings. Below we break down the key numbers, what changed today, and what to watch next.


Key takeaways

  • Lattice Semiconductor posted Q3 FY2025 revenue of $133.3M and non‑GAAP EPS of $0.28, reiterating Q4 revenue guidance of $138M–$148M and EPS of $0.30–$0.34 (midpoint implies ~22% YoY revenue growth). [1]
  • New today (Nov. 6): coverage aggregators show LSCC holding a “Moderate Buy” consensus and fresh/recent $80–$82 price targets from the sell side following the print. [2]
  • Benchmark Electronics reported Q3 revenue of ~$681M (+3.5% YoY) with GAAP EPS of $0.39 (non‑GAAP $0.62); today’s 10‑Q offers more detail on the quarter after earlier headlines about an income dip. BHE also guided Q4 revenue to $670M–$720M and EPS to $0.62–$0.68. [3]

Lattice Semiconductor (LSCC): in‑line quarter, solid AI/data‑center tailwinds

Lattice’s Q3 FY2025 numbers came in in line with expectations: revenue $133.3M (+4.9% YoY, +7.6% QoQ), GAAP gross margin 67.9%, non‑GAAP gross margin 69.5%, GAAP net income $2.8M ($0.02), and non‑GAAP EPS $0.28. Management guided Q4 revenue to $138M–$148M and non‑GAAP EPS to $0.30–$0.34, and flagged non‑GAAP OPEX of $54.5M–$56.5M. [4]

Today’s pushback-and-forth in sentiment stems from Monday’s “met/inline” print and 22% YoY Q4 growth guide, followed by ongoing analyst commentary. MarketBeat’s feed today shows consensus “Moderate Buy” and price‑target lifts (e.g., Benchmark to $82; several peers around $80), framing the stock’s setup into year‑end. [5]

Context: Earlier wire stories captured a sharp post‑print swing in LSCC shares on Nov. 4; by today, coverage has tilted to what the guide implies for AI‑server and communications demand into Q4. [6]

What to watch next for LSCC

  • Execution vs. Q4 guide: whether bookings in communications/data‑center translate to the $143M midpoint and margin profile management outlined. [7]
  • Analyst trajectory: will price‑target momentum continue if orders/inventory normalization hold? (Multiple items today reaffirm a constructive stance.) [8]
  • Primary source docs: investors can cross‑check details in the earnings call materials/transcripts posted this week. [9]

Additional background: The AP/Zacks earnings snapshot earlier this week also recorded $133.3M revenue and $0.28 adjusted EPS, matching Street consensus—useful for headline‑level confirmation. [10]


Benchmark Electronics (BHE): 10‑Q lands today after Q3 “up revenue, down income” mix

BHE’s headline Q3 outcomes: revenue $681M (+3.5% YoY), GAAP EPS $0.39, non‑GAAP EPS $0.62, reflecting broad‑based sequential growth and stronger Medical/Aerospace & Defense. Q4 guidance calls for $670M–$720M revenue and $0.62–$0.68 EPS. [11]

New today (Nov. 6): the company’s Form 10‑Q hit the tape, offering granular segment/expense detail behind that “income down vs. last year” narrative that circulated on Nov. 4 (RTTNews). The 10‑Q summary shows sales of ~$680.7M and diluted GAAP EPS of $0.39 for Q3; it also updates year‑to‑date comparisons. [12]

Coverage in the last 24 hours underscores that Q4 guide brackets consensus and that BHE reached the high end of prior guidance in Q3, with AI‑adjacent opportunities a talking point on the call. [13]

What to watch next for BHE

  • Q4 mix and margins: whether momentum in Medical & A&D offsets softer pockets and supports the $0.62–$0.68 EPS guide. [14]
  • Cash flow/working capital detail in the 10‑Q and any implications for 2026 capital returns. [15]
  • Follow‑up commentary from management/analysts as the post‑print digestion continues. [16]

The market narrative today (Nov. 6)

  • LSCC: After a volatile reaction to Monday’s inline print, today’s flow skews toward constructive sell‑side positioning and focus on the Q4 acceleration. Investors are parsing whether AI‑driven communications and compute demand can carry through to margins amid still‑elevated OPEX. [17]
  • BHE: With the 10‑Q now posted, the mix of “revenue up, GAAP income down” vs. last year is better contextualized, while Q4 guidance sets a clear near‑term hurdle. [18]

Methodology & sources (selected)

  • Company releases & IR: Lattice Q3 FY2025 press release and guidance; Benchmark Q3 FY2025 results & guidance. [19]
  • Regulatory filings: Today’s BHE Form 10‑Q summary; LSCC recent filings overview. [20]
  • Independent coverage: AP/Zacks LSCC earnings snapshot; Nasdaq/RTTNews note on BHE income decline; analyst/consensus items posted today for LSCC. [21]
  • Call/transcript roundups: Yahoo Finance and Investing.com summaries for context. [22]

Bottom line

For LSCC, the story into year‑end is whether the Q4 guide translates into tangible AI/communications‑led growth and sustained margin quality. For BHE, the 10‑Q helps reconcile headline GAAP income pressure with healthy revenue trajectory and in‑range Q4 guidance. As of Nov. 6, 2025, both names remain event‑driven: LSCC by analyst recalibration after an inline print, BHE by execution vs. Q4 targets now that the filing is out. [23]

Tickers: LSCC, BHE.

Elon Musk: Nvidia's GPUs are 'better than what we make'

References

1. www.businesswire.com, 2. www.marketbeat.com, 3. www.businesswire.com, 4. www.businesswire.com, 5. www.marketbeat.com, 6. www.marketbeat.com, 7. www.businesswire.com, 8. www.marketbeat.com, 9. finance.yahoo.com, 10. www.nhregister.com, 11. www.businesswire.com, 12. www.stocktitan.net, 13. au.investing.com, 14. www.businesswire.com, 15. www.stocktitan.net, 16. seekingalpha.com, 17. www.marketbeat.com, 18. www.stocktitan.net, 19. www.businesswire.com, 20. www.stocktitan.net, 21. www.nhregister.com, 22. finance.yahoo.com, 23. www.businesswire.com

Stock Market Today

  • Is Elevance Health a Hidden Opportunity After a 24.5% Drop in 2025?
    November 6, 2025, 7:28 AM EST. Elevance Health has tumbled in 2025 amid policy shifts and broader healthcare-sector volatility, with a year-to-date drawdown and a longer 24.5% slide that has investors rethinking value. The piece weighs near- and long-term catalysts, noting that a high valuation score isn't translating into certainty as government program changes loom for managed care. The core takeaway is a rigorous DCF assessment, which, using current free cash flow of $3.6B and projected growth, yields an intrinsic value around $1,090.84 per share-roughly 71% above current prices, signaling undervaluation. Still, equity investors should monitor the PE ratio, competitive dynamics, and policy risk, which could affect how quickly this perceived bargain translates into realized gains.
  • Inflammation Biotech Evommune Starts NYSE Trading in $150M IPO
    November 6, 2025, 7:24 AM EST. Evommune is heading to the NYSE with a $150 million IPO to fund two clinical-stage assets. The Palo Alto biopharma is offering 9.3 million shares at $16 each, pricing in the $15-$17 range. Gross proceeds are $150 million, potentially rising by about $22.5 million if underwriters exercise their option for an additional 1.4 million shares. Trading under the ticker EVMN could begin today. The company plans to use the funds to advance two phase 2 programs, including EVO756, an oral MRGPRX2 antagonist being studied for CSU and atopic dermatitis (AD). Topline data for CSU from a phase 2 study showed 93% responses at four weeks. Data for AD topline in H2 2026. Evommune priced amid a broader biotech IPO backdrop as MapLight Therapeutics went public last week.
  • Arm Holdings Stock Surges on Q2 Beat, Strong AI Demand Lifts Outlook
    November 6, 2025, 7:22 AM EST. Arm Holdings (ARM) stock jumps about 5-6% in pre-market trading after reporting a Q2 beat that topped revenue and earnings estimates and issuing stronger Q3 guidance. The company posted revenue of $1.14 billion, up 34% year over year, and EPS of $0.22, exceeds consensus of $0.13. Arm also raised its quarterly revenue guide to about $1.23 billion versus the $1.10 billion expected. Royalty revenue reached a record $620 million, up 21%, led by data centers, automotive, and IoT, with hyperscalers like Google, Amazon, and Microsoft boosting Arm-based deployments. Licensing revenue rose 56% to $515 million. The AI infrastructure buildout underscores demand for Arm's energy-efficient designs, and management hints at potential in-house chip development beyond licensing.
  • Capital One Stock Prediction: Analysts See Up to 29% Upside by 2027 on Discover Acquisition
    November 6, 2025, 7:20 AM EST. Capital One (NYSE: COF) trades around $221 with an average target near $260, implying ~18% upside. Targets span $290 (high) and $210 (low), with a median near $258 and a mix of 14 Buys, 3 Outperforms, and 6 Holds. Growth projections call for revenue up about 19% annually through 2027, supported by operating margins near 48% and a forward multiple around 9.7x. A guided model points to ~$285/share by 2027, or about 29% total upside (12% annualized). The story centers on the Discover acquisition, expanded payments network, and stable credit trends amid solid consumer spending, though conviction remains modest and upside depends on continued earnings growth and credit stability.
  • Three Stocks Added to Zacks Rank #5 Strong Sell List on Nov. 6: ACHC, FWRD, CENX
    November 6, 2025, 7:18 AM EST. Three names were added to Zacks Rank #5 (Strong Sell) today: Acadia Healthcare (ACHC), Forward Air (FWRD), and Century Aluminum (CENX). For the current year, earnings estimates were revised downward by 3.2%, 12%, and 11.7% over the last 60 days, respectively. The update reinforces the Strong Sell roster per Zacks research. The piece also highlights a separate feature on a stock most likely to double and a prompt to download Zacks' top stock ideas.
Fed Cuts Rates Amid Data “Fog” – Stocks Hit Record Highs as More Easing Likely
Previous Story

Fed Liquidity Watch (Nov. 6, 2025): Record SRF Usage Fades After $50B Spike—What the “$125B in 5 Days” Headlines Really Mean for Banks and Markets

Kraken Lists ASTER: Is This New DeFi Token the Next Big Thing?
Next Story

Aster (ASTER) Rebounds Above $1 on Nov. 6: $29M Buybacks, CZ’s 2M-Token Disclosure, and New Collateral Utility Fuel the Rally

Go toTop